Increased circulating myostatin in patients with type 2 diabetes mellitus. (Q51318351)

3 April 2018

title

Increased circulating myostatin in patients with type 2 diabetes mellitus. (English)

1 reference

3 April 2018

1 reference

Fang Wang

1

1 reference

3 April 2018

Yonggan Liao

2

1 reference

3 April 2018

Xuefeng Li

3

1 reference

3 April 2018

Chunlin Ren

4

1 reference

3 April 2018

Changming Cheng

5

1 reference

3 April 2018

Yongsheng Ren

6

1 reference

3 April 2018

publication date

11 August 2012

1 reference

3 April 2018

Journal of Huazhong University of Science and Technology [Medical Sciences]

published in

1 reference

3 April 2018

volume

32

1 reference

3 April 2018

issue

4

1 reference

3 April 2018

page(s)

534-539

1 reference

3 April 2018

The burden of non communicable diseases in developing countries

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11596-012-0092-9

Type 2 diabetes: principles of pathogenesis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-012-0092-9

Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-012-0092-9

Regulation of myostatin activity and muscle growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-012-0092-9

Regulation of GDF-8 signaling by the p38 MAPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-012-0092-9

Myostatin induces cyclin D1 degradation to cause cell cycle arrest through a phosphatidylinositol 3-kinase/AKT/GSK-3 beta pathway and is antagonized by insulin-like growth factor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-012-0092-9

Myostatin signaling through Smad2, Smad3 and Smad4 is regulated by the inhibitory Smad7 by a negative feedback mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-012-0092-9

Inhibition of preadipocyte differentiation by myostatin treatment in 3T3-L1 cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-012-0092-9

Myostatin regulates glucose metabolism via the AMP-activated protein kinase pathway in skeletal muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-012-0092-9

Myostatin is a human placental product that regulates glucose uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-012-0092-9

Suppression of body fat accumulation in myostatin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-012-0092-9

Myostatin mutation associated with gross muscle hypertrophy in a child

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-012-0092-9

Fat partitioning and biochemical characteristics of fatty tissues in relation to plasma metabolites and hormones in normal and double-muscled young growing bulls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-012-0092-9

Transgenic expression of myostatin propeptide prevents diet-induced obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-012-0092-9

FSTL3 deletion reveals roles for TGF-beta family ligands in glucose and fat homeostasis in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-012-0092-9

Myostatin, activin receptor IIb, and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-012-0092-9

Changes in muscle myostatin expression in obese subjects after weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-012-0092-9

Increased secretion and expression of myostatin in skeletal muscle from extremely obese women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-012-0092-9

Myostatin, insulin-like growth factor-1, and leukemia inhibitory factor mRNAs are upregulated in chronic human disuse muscle atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-012-0092-9

Myostatin up-regulation is associated with the skeletal muscle response to hypoxic stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-012-0092-9

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-012-0092-9

Impact of exercise training on myostatin expression in the myocardium and skeletal muscle in a chronic heart failure model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-012-0092-9

Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-012-0092-9

Regulation of myostatin in vivo by growth and differentiation factor-associated serum protein-1: a novel protein with protease inhibitor and follistatin domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-012-0092-9

Genetic analysis of the role of proteolysis in the activation of latent myostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-012-0092-9

Upregulation of myostatin gene expression in streptozotocin-induced type 1 diabetes mice is attenuated by insulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-012-0092-9

Stimulation of skeletal muscle myofibrillar protein synthesis, p70 S6 kinase phosphorylation, and ribosomal protein S6 phosphorylation by inhibition of myostatin in mature mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-012-0092-9

Regulation of myostatin expression and myoblast differentiation by FoxO and SMAD transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-012-0092-9

Effect of RNA oligonucleotide targeting Foxo-1 on muscle growth in normal and cancer cachexia mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-012-0092-9

A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-012-0092-9

Serum myostatin-immunoreactive protein is increased in 60-92 year old women and men with muscle wasting

21 January 2018

1 reference

12 December 2020

Plasma myostatin-immunoreactive protein is increased after prolonged bed rest with low-dose T3 administration

1 reference

12 December 2020

Myostatin Knockout in Mice Increases Myogenesis and Decreases Adipogenesis

1 reference

12 December 2020

Regulation of myostatin signaling by c-Jun N-terminal kinase in C2C12 cells

1 reference

12 December 2020

Androgens negatively regulate myostatin expression in an androgen-dependent skeletal muscle

1 reference

12 December 2020

Cachexia: pathophysiology and clinical relevance

1 reference

12 December 2020

Protein metabolism in insulin-dependent diabetes mellitus

1 reference

12 December 2020

10.1007/S11596-012-0092-9

Identifiers

DOI

1 reference

3 April 2018

1 reference

3 April 2018